Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider.
A Comparison of Supervised Machine Learning Algorithms and Feature Vectors for MS Lesion Segmentation Using Multimodal Structural MRI.
Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.
The Bioenergetic Health Index: a new concept in mitochondrial translational research.
Sub-millimeter imaging of brain-free water for rapid volume assessment in atrophic brains.
Prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: a blinded sonographic evaluation.
Preparation and characterization of Δ(9)-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines.
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes.
Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production.
Brain-Derived Neurotrophic Factor in Neuroimmunology: Lessons Learned from Multiple Sclerosis Patients and Experimental Autoimmune Encephalomyelitis Models.
Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation.
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.
Adolescents' experiences on coping with parental multiple sclerosis: a grounded theory study.
An unusual case of recurrent Guillain-Barré syndrome with normal cerebrospinal fluid protein levels: a case report.
New TYSABRI® analysis at AAN annual meeting shows improved walking speed in significant number of MS patients
Decreased hydrocortisone sensitivity of T cell function in multiple sclerosis-associated major depression.
Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy.
Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.
Multiple Sclerosis: A Disease of Affluence?.
CC3-03: Drug Characteristics Associated with Medication Adherence Across Eight Disease States.
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis.
Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis.
Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions.
The first 10 years with multiple sclerosis: The longitudinal course of daily functioning.
Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population.
Pages
« first
‹ previous
…
230
231
232
233
234
235
236
237
238
…
next ›
last »